Share on StockTwits

Shares of Gentiva Health Services (NASDAQ:GTIV) reached a new 52-week high on Thursday , Analyst Ratings Network reports. The company traded as high as $18.49 and last traded at $18.12, with a volume of 48,608 shares traded. The stock had previously closed at $18.36.

GTIV has been the subject of a number of recent research reports. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Gentiva Health Services in a research note on Friday, July 18th. They now have a $17.25 price target on the stock, up previously from $14.50. Separately, analysts at Zacks upgraded shares of Gentiva Health Services from a “neutral” rating to an “outperform” rating in a research note on Wednesday, July 16th. They now have a $19.00 price target on the stock. Finally, analysts at CRT Capital downgraded shares of Gentiva Health Services from a “buy” rating to a “fair value” rating in a research note on Tuesday, June 24th. They now have a $16.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $15.61.

The stock’s 50-day moving average is $15.50 and its 200-day moving average is $11.57. The company’s market cap is $669.8 million.

Gentiva Health Services (NASDAQ:GTIV) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $487.50 million for the quarter, compared to the consensus estimate of $491.51 million. During the same quarter in the previous year, the company posted $0.23 earnings per share. The company’s revenue for the quarter was up 17.3% on a year-over-year basis. Analysts expect that Gentiva Health Services will post $0.91 EPS for the current fiscal year.

Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.